Perceptive Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,150,641
| Closed | -$14.4M | – | 121 |
|
|
2022
Q3 | $14.4M | Hold |
2,150,641
| – | – | 0.42% | 55 |
|
|
2022
Q2 | $9.05M | Hold |
2,150,641
| – | – | 0.28% | 63 |
|
|
2022
Q1 | $7.25M | Hold |
2,150,641
| – | – | 0.15% | 92 |
|
|
2021
Q4 | $6.77M | Hold |
2,150,641
| – | – | 0.1% | 107 |
|
|
2021
Q3 | $7.03M | Hold |
2,150,641
| – | – | 0.1% | 110 |
|
|
2021
Q2 | $9.08M | Hold |
2,150,641
| – | – | 0.12% | 111 |
|
|
2021
Q1 | $10.7M | Hold |
2,150,641
| – | – | 0.14% | 94 |
|
|
2020
Q4 | $27.2M | Hold |
2,150,641
| – | – | 0.29% | 69 |
|
|
2020
Q3 | $21.1M | Hold |
2,150,641
| – | – | 0.31% | 66 |
|
|
2020
Q2 | $21.4M | Hold |
2,150,641
| – | – | 0.35% | 58 |
|
|
2020
Q1 | $19.5M | Hold |
2,150,641
| – | – | 0.51% | 42 |
|
|
2019
Q4 | $19.8M | Sell |
2,150,641
-44,000
| -2% | -$406K | 0.39% | 46 |
|
|
2019
Q3 | $12.9M | Sell |
2,194,641
-10,000
| -0.5% | -$58.8K | 0.35% | 51 |
|
|
2019
Q2 | $26.5M | Hold |
2,204,641
| – | – | 0.61% | 42 |
|
|
2019
Q1 | $26.6M | Buy |
2,204,641
+330,862
| +18% | +$3.99M | 0.75% | 35 |
|
|
2018
Q4 | $22.8M | Buy |
+1,873,779
| New | +$22.8M | 0.87% | 32 |
|
|
2015
Q4 | – | Sell |
-10,379
| Closed | -$195K | – | 173 |
|
|
2015
Q3 | $195K | Buy |
+10,379
| New | +$195K | 0.02% | 120 |
|